United States
# |
Name |
Operating Income Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
38.66%
|
Sept. 30, 2024 | USD 50.77 | 2.13% |
|
United States |
|
2 |
33.79%
|
Sept. 30, 2024 | USD 54.93 | 4.23% |
|
United States |
|
3 |
33.14%
|
Sept. 30, 2024 | USD 61.49 | 0.77% |
|
United States |
|
4 |
31.68%
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
5 |
30.03%
|
Sept. 30, 2024 | USD 1.27 K | 0.33% |
|
United States |
|
6 |
29.91%
|
Sept. 30, 2024 | USD 57.52 | 1.79% |
|
United States |
|
7 |
29.50%
|
Sept. 30, 2024 | USD 228.83 | -0.62% |
|
United States |
|
8 |
28.91%
|
Sept. 30, 2024 | USD 6.64 | 4.08% |
|
United States |
|
9 |
27.19%
|
Sept. 30, 2024 | USD 71.04 | -0.07% |
|
United States |
|
10 |
26.24%
|
Sept. 30, 2024 | USD 538.88 | -0.16% |
|
United States |
|
11 |
25.40%
|
Sept. 30, 2024 | USD 179.15 | 1.50% |
|
United States |
|
12 |
23.26%
|
Sept. 30, 2024 | USD 95.85 | 1.78% |
|
United States |
|
13 |
23.21%
|
Sept. 28, 2024 | USD 70.20 | -0.13% |
|
United States |
|
14 |
20.37%
|
Sept. 30, 2024 | USD 362.80 | 0.50% |
|
United States |
|
15 |
18.12%
|
Sept. 30, 2024 | USD 104.71 | -0.74% |
|
United States |
|
16 |
17.84%
|
Sept. 30, 2024 | USD 267.04 | -0.35% |
|
United States |
|
17 |
17.75%
|
Sept. 30, 2024 | USD 20.10 | 0.95% |
|
United States |
|
18 |
17.33%
|
Sept. 30, 2024 | USD 95.65 | 1.10% |
|
United States |
|
19 |
17.17%
|
Sept. 30, 2024 | USD 210.46 | -1.51% |
|
United States |
|
20 |
16.92%
|
Sept. 28, 2024 | USD 556.99 | 0.27% |
|
United States |
|
21 |
16.73%
|
Sept. 30, 2024 | USD 113.02 | -0.15% |
|
United States |
|
22 |
16.32%
|
Sept. 29, 2024 | USD 179.17 | 0.35% |
|
United States |
|
23 |
15.88%
|
Sept. 30, 2024 | USD 79.17 | -0.84% |
|
United States |
|
24 |
15.12%
|
Sept. 30, 2024 | USD 70.19 | 2.45% |
|
United States |
|
25 |
14.71%
|
Sept. 30, 2024 | USD 45.00 | -3.72% |
|
United States |
|
26 |
14.63%
|
Sept. 30, 2024 | USD 67.79 | -2.46% |
|
United States |
|
27 |
14.28%
|
Sept. 30, 2024 | USD 15.16 | 0.20% |
|
United States |
|
28 |
14.19%
|
Sept. 28, 2024 | USD 79.96 | 0.69% |
|
United States |
|
29 |
13.63%
|
Sept. 30, 2024 | USD 111.11 | 1.26% |
|
United States |
|
30 |
13.14%
|
Sept. 30, 2024 | USD 84.13 | -1.40% |
|
United States |
|
31 |
13.08%
|
Sept. 30, 2024 | USD 235.80 | -0.17% |
|
United States |
|
32 |
12.46%
|
Sept. 27, 2024 | USD 148.22 | 1.40% |
|
United States |
|
33 |
12.31%
|
Sept. 27, 2024 | USD 138.83 | 2.72% |
|
United States |
|
34 |
11.43%
|
Sept. 30, 2024 | USD 99.89 | 4.44% |
|
United States |
|
35 |
10.13%
|
Sept. 30, 2024 | USD 61.26 | -2.69% |
|
United States |
|
36 |
9.15%
|
Sept. 28, 2024 | USD 22.64 | 0.85% |
|
United States |
|
37 |
8.63%
|
Sept. 30, 2024 | USD 10.37 | 0.39% |
|
United States |
|
38 |
8.56%
|
Sept. 28, 2024 | USD 105.78 | 2.21% |
|
United States |
|
39 |
8.47%
|
Sept. 30, 2024 | USD 15.83 | 0.19% |
|
United States |
|
40 |
7.84%
|
Sept. 30, 2024 | USD 62.54 | -2.36% |
|
United States |
|
41 |
7.84%
|
Sept. 30, 2024 | USD 8.00 | 1.01% |
|
United States |
|
42 |
7.70%
|
Sept. 28, 2024 | USD 166.09 | 0.31% |
|
United States |
|
43 |
7.53%
|
Sept. 30, 2024 | USD 17.46 | 1.51% |
|
United States |
|
44 |
7.01%
|
June 30, 2024 | USD 8.43 | 2.18% |
|
United States |
|
45 |
6.74%
|
Sept. 30, 2024 | USD 252.89 | 2.41% |
|
United States |
|
46 |
6.64%
|
Sept. 30, 2024 | USD 88.18 | 1.15% |
|
United States |
|
47 |
6.30%
|
Sept. 30, 2024 | USD 65.65 | -1.41% |
|
United States |
|
48 |
5.56%
|
Sept. 30, 2024 | USD 21.93 | -1.62% |
|
United States |
|
49 |
5.37%
|
Sept. 30, 2024 | USD 131.05 | -0.04% |
|
United States |
|
50 |
4.57%
|
Sept. 30, 2024 | USD 7.66 | -1.42% |
|
United States |
The Medical Instruments company in United States with the highest Operating Income Margin is Doximity, Inc. (NYSE: DOCS) at 38.66%.
The Medical Instruments company in United States with the lowest Operating Income Margin is Sharps Technology, Inc. (NasdaqCM: STSS) at -121,872.82%.
The top 10 Medical Instruments companies in United States by Operating Income Margin are Doximity, Inc., Semler Scientific, Inc., Utah Medical Products, Inc., Lantheus Holdings, Inc., Mettler-Toledo International Inc., IRadimed Corporation, ResMed Inc., Sensus Healthcare, Inc., Edwards Lifesciences Corporation and Intuitive Surgical, Inc..
The bottom 10 Medical Instruments companies in United States by Operating Income Margin are Sharps Technology, Inc., Heart Test Laboratories, Inc., BioSig Technologies, Inc., SeaStar Medical Holding Corporation, Envoy Medical, Inc., Vivani Medical, Inc., Nexalin Technology, Inc., enVVeno Medical Corporation, Orchestra BioMed Holdings, Inc. and Movano Inc..